Moloney Mark G, Trippier Paul C, Yaqoob Muhammad, Wang Zhaoyang
The Department of Chemistry, The University of Oxford, Chemical Research Laboratory, Mansfield Road, Oxford. OX1 3TA, UK.
Curr Drug Discov Technol. 2004 Oct;1(3):181-99. doi: 10.2174/1570163043334974.
Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.
